Biotech Series C Investors & VC Firms
430 firms in this list, with a median first check of $648K. 101 of them lead rounds. Generated from verified public data and updated continuously.
Black Opal Ventures
New YorkSeed–Late Stage
18 people
Venture Ontario
TorontoSeed–Growth
3 people
BRM Capital
Tel AvivSeed–Growth
14 people
Wormhole Capital
Pre-Seed–Growth
2 people
Clay Capital
Seed–Series C$3M – $8M
18 people
MSD Global Health Innovation Fund
RahwaySeries A–Late Stage$2M – $10M
10 people
HBM Partners
ZugSeed–Late Stage$5M – $50M
6 people
Sciety
StockholmSeed–Growth
23 people
Delos Capital
CambridgeSeed–Growth
13 people
Eaton Square
LondonSeries A–Growth
25 people
LifeSci Venture Partners
New YorkSeries A–Series C
6 people
Creathor Ventures
Bad HomburgSeed–Late Stage$540K – $10.8M
2 people
ACT Venture Capital
DublinSeed–Growth$1.1M – $16.2M
11 people
Crossbeam Venture Partners
New YorkPre-Seed–Late Stage$1M – $1.5M
8 people
Neva Sgr.
TurinSeries A–Growth
8 people
DNA Capital
São PauloSeed–Late Stage$100K – $5M
15 people
Pappas Capital
Research Triangle ParkSeed–Late Stage$100K – $6M
15 people
Invus
New YorkSeed–Late Stage
8 people
Alkemi Growth Capital
New DelhiPre-Seed–Growth
15 people
New Science Ventures
GreenwichSeed–Late Stage$2M – $8M
7 people
INCE Capital
ShanghaiSeed–Growth
12 people
JK&B Capital
ChicagoSeed–Late Stage
9 people
CPT Capital
LondonPre-Seed–Late Stage
7 people
Fall Line Capital
San MateoSeries A–Series C
11 people
Related lists
Biotech Investors & VC Firms (2504)Biotech Seed Investors & VC Firms (2043)Series C Investors & VC Firms (1709)Biotech Series A Investors & VC Firms (1638)Biotech Investors & VC Firms in North America (1618)Biotech Investors & VC Firms in United States (1466)Biotech Investors & VC Firms in Europe (961)Series C Investors & VC Firms in North America (942)Biotech Pre-Seed Investors & VC Firms (931)Biotech Investors & VC Firms in Global (826)
Data sourced from public filings and firms' own websites — see our methodology.





























































































